tresibe pen

Tresiba is a long-acting basal insulin analogue containing insulin degludec. It is used to improve glycemic control in adults, adolescents, and children from the age of 1 year with diabetes mellitus. Tresiba provides a flat and stable glucose-lowering effect with a duration of action beyond 42 hours, significantly reducing the risk of nocturnal hypoglycemia compared to older basal insulins. The pre-filled FlexTouch pen allows for easy and precise dosing.